We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

174 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $43.9M | Put options by funds: $18M

0% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 24

0% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 53

1% less funds holding

Funds holding: 175 → 174 (-1)

29% less capital invested

Capital invested by funds: $1.42B → $1.01B (-$408M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
174
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
53
Reduced
53
Closed
24
Calls
$43.9M
Puts
$18M
Net Calls
+$25.9M
Net Calls Change
+$35.6M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$21M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$15.3M
4
Bank of America
Bank of America
North Carolina
+$14.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$26.4M
2
PHS
PFM Health Sciences
California
-$23.6M
3
SCM
Scopia Capital Management
New York
-$13.7M
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.07M
5
BBA
Baker Bros. Advisors
New York
-$4.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
SLF
126
Sun Life Financial
Ontario, Canada
$246K +$108K +35 +51%
BMC
127
Benin Management Corp
Connecticut
$230K – – –
MSA
128
Mason Street Advisors
Wisconsin
$229K -$49.5K -16 -14%
RJA
129
Raymond James & Associates
Florida
$223K -$2.72M -880 -90%
Public Employees Retirement Association of Colorado
130
Public Employees Retirement Association of Colorado
Colorado
$216K – – –
GHCM
131
Glen Harbor Capital Management
California
$208K – – –
XK
132
Xact Kapitalforvaltning
Sweden
$206K – – –
TRSOTSOK
133
Teachers Retirement System of the State of Kentucky
Kentucky
$198K -$15.5K -5 -6%
Ohio Public Employees Retirement System (OPERS)
134
Ohio Public Employees Retirement System (OPERS)
Ohio
$180K +$118K +38 +100%
MAM
135
Meeder Asset Management
Ohio
$176K +$207K +67 +957%
MCIM
136
Meadow Creek Investment Management
Georgia
$172K – – –
QT
137
Quantbot Technologies
New York
$170K +$223K +72 New
SAM
138
Shell Asset Management
Netherlands
$151K +$198K +64 New
EP
139
Elkfork Partners
Oregon
$135K – – –
SDIC
140
South Dakota Investment Council
South Dakota
$116K +$152K +49 New
Schroder Investment Management Group
141
Schroder Investment Management Group
United Kingdom
$112K +$145K +47 New
RCM
142
Riverhead Capital Management
Delaware
$110K – – –
Pacer Advisors
143
Pacer Advisors
Pennsylvania
$110K +$142K +46 New
TAM
144
Tyers Asset Management
Texas
$98K – – –
Macquarie Group
145
Macquarie Group
Australia
$83K +$65K +21 +150%
AIP
146
Ameritas Investment Partners
Nebraska
$73K – – –
Zurich Cantonal Bank
147
Zurich Cantonal Bank
Switzerland
$61K – – –
FGAM
148
Financial Gravity Asset Management
Texas
$48K +$68.1K +22 New
LTFS
149
Ladenburg Thalmann Financial Services
Florida
$43K – – –
SA
150
SRH Advisors
Kansas
$36K – – –
4 5
6
7 8

ACOR Hedge Fund Activity: Q3 2018 in Review

174 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2018, worth a combined $1.01B — down 29% from $1.42B a quarter earlier.

Fund positioning in ACOR was balanced in Q3 2018: 24 funds opened new positions, 24 closed out, 53 added to existing stakes and 53 trimmed.

The largest buyer was State Street, adding an estimated $21M. The largest seller was BlackRock, cutting an estimated $26.4M.

  • 174 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2018, down from 175 in Q2 2018.
  • Funds reported $1.01B of Acorda Therapeutics stock for Q3 2018, down 29% quarter-over-quarter.
  • 24 funds opened new Acorda Therapeutics positions in Q3 2018 and 24 closed out, a net change of 0 holders.
  • The largest Acorda Therapeutics buyer in Q3 2018 was State Street, an estimated $21M added.
  • The largest Acorda Therapeutics seller in Q3 2018 was BlackRock, an estimated $26.4M sold.

Based on aggregated 13F filings for Q3 2018.